SyneuRx International (Taiwan) Corp. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 1.32 million.

Net loss was TWD 132.55 million compared to TWD 353.1 million a year ago. Basic loss per share from continuing operations was TWD 1 compared to TWD 2.92 a year ago.